Pralatrexate (PDX) produces durable complete remissions in patients with chemotherapy resistant precursor and peripheral T-Cell lymphomas: Results of the MSKCC phase I/II experience.

被引：0
|
作者：
O'Connor, Owen A.
Hamlin, P. A.
Gerecitano, J.
Portlock, C. S.
Noy, A.
Moskowitz, C.
Straus, D. J.
Sarasohn, D.
Dumetrescu, O.
Pappanicolou, J.
Neylon, E.
Zelenetz, A. D.
Saunders, M. E.
Mould, D. R.
Fleischer, M.
Sirotnak, F.
Horwitz, S. M.
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[2] Allos Therapeut Inc, Westminster, CO USA
[3] Project Res, Phoenix, AZ USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
400
引用
收藏
页码：122A / 123A
页数：2
相关论文
共 50 条
  • [41] DOSE-DENSE INDUCTION FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) LEADS TO SUSTAINED REMISSIONS IN A LARGE FRACTION OF PATIENTS WITH PREVIOUSLY UNTREATED PERIPHERAL T-CELL LYMPHOMAS (PTCLS) - OVERALL AND SUBTYPE-SPECIFIC RESULTS OF A PHASE II STUDY FROM THE NORDIC LYMPHOMA GROUP
    D'Amore, F.
    Relander, T.
    Lauritzen, G. F.
    Jantunen, E.
    Hagberg, H.
    Anderson, H.
    Cavallin-Stahl, E.
    Holte, H.
    Osterborg, A.
    Merup, M.
    Brown, P.
    Kuittinen, O.
    Erlanson, M.
    Telhaug, R.
    Gadeberg, O.
    Sundstrom, C.
    Delabie, J.
    Ralfkiaer, E.
    Vornanen, M.
    Jensen, C. B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 437 - 437
  • [42] A Phase II Trial of Brentuximab Vedotin (BV) and Lenalidomide (Len) in Relapsed and Refractory (r/r) Cutaneous (CTCL) and Peripheral (PTCL) T-Cell Lymphomas; Preliminary Results
    William, Basem
    Huang, Ying
    Brammer, Jonathan
    Chung, Catherine
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S359 - S360
  • [43] Efficacy and Safety of Valemetostat Monotherapy in Patients with Relapsed or Refractory Peripheral T-Cell Lymphomas: Primary Results of the Phase 2 VALENTINE-PTCL01 Study
    Horwitz, Steven M.
    Izutsu, Koji
    Mehta-Shah, Neha
    Cordoba, Raul
    Barta, Stefan K.
    Bachy, Emmanuel
    Gritti, Giuseppe
    Jacobsen, Eric
    Kusumoto, Shigeru
    Guillermin, Yann
    Prica, Anca
    Yoon, Dok Hyun
    Domenech, Eva Domingo
    Wang, Jie
    Kim, Jin Seok
    Cwynarski, Kate
    van der Poel, Marjolein
    Inoue, Ai
    Jin, Jin
    Wu, Sutan
    Nakajima, Keiko
    Zinzani, Pier Luigi
    BLOOD, 2023, 142
  • [44] Results of high dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma (PTCL).: The Spanish lymphoma cooperative group experience (GEL/TAMO).
    Rodríguez, J
    Caballero, MD
    Gutiérrez, A
    Sierra, J
    López-Guillermo, A
    Marín, J
    Sarra, J
    Lahuerta, JJ
    Rifon, J
    Conde, E
    BLOOD, 2001, 98 (11) : 680A - 680A
  • [45] Front-line autologous stem cell transplantation as intensive consolidation in patients with newly diagnosed peripheral T-cell lymphomas: multicentre, phase II clinical trial in Korea
    Yang, D. H.
    Ahn, J. S.
    Lee, S. R.
    Sohn, S. K.
    Moon, J. H.
    Song, M. K.
    Jung, J. S.
    Kwak, J. Y.
    Lee, J. J.
    Kim, H. J.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S250 - S251
  • [46] Phase I/II trials of autologous peripheral blood stem cell transplantation in autoimmune diseases resistant to conventional therapy:: Preliminary results from the Spanish experience
    Espigado, I
    Marín-Niebla, A
    Rovira, M
    Juliá, A
    Rodríguez, JM
    Alté, A
    Arranz, R
    Bargay, J
    Diez, JL
    Forés, R
    Morales, A
    Graus, F
    Messague, I
    Hernández, JC
    Parody, R
    Richard, C
    Ferrá, C
    García, A
    Carreras, E
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (02) : 742 - 743
  • [47] The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission:: the Spanish Lymphoma and Autologous Transplantation Group experience
    Rodriguez, J.
    Conde, E.
    Gutierrez, A.
    Arranz, R.
    Leon, A.
    Marin, J.
    Bendandi, M.
    Albo, C.
    Caballero, M. D.
    ANNALS OF ONCOLOGY, 2007, 18 (04) : 652 - 657
  • [48] A phase II study of derdleukin diftitox (Ontak®) with CHOP chemotherapy in patients with newly-diagnosed aggressive T-cell lymphomas, the CONCEPT trial:: Interim analysis.
    Foss, Francine M.
    Sjak-Shie, Nelida
    Goy, Andre
    Advani, Ranjana
    Jacobsen, Eric
    Acosta, Mark
    BLOOD, 2006, 108 (11) : 696A - 697A
  • [49] Phase I/II trials of autologous peripheral blood stem cell transplantation (ASCT) in autoimmune diseases (AID) resistant to conventional therapy:: preliminary results of the Spanish experience
    Espigado, I
    Rovira, M
    Juliá, A
    Rodríguez, J
    Altés, A
    Arranz, R
    Bargay, J
    Díez, J
    Forés, R
    Morales, A
    Graus, F
    Messague, I
    Solano, C
    Parody, R
    Richard, C
    Ferrá, C
    García, A
    Carreras, E
    BONE MARROW TRANSPLANTATION, 2002, 29 : S15 - S15
  • [50] Phase II study of compound GW506U78 (AraG) for patients with indolent B-cell or peripheral T-cell lymphoma previously treated with chemotherapy
    Goy, A
    Bleyer, A
    Hagemeister, F
    Fayad, L
    Pro, B
    Romaguera, J
    Samaniego, F
    Sarris, AH
    Hart, S
    Cabanillas, F
    Murgo, A
    Duvic, M
    Rodriguez, MA
    BLOOD, 2003, 102 (11) : 639A - 639A
12345